Scientific Literature Search

Source record

Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in Parkinson's disease.

Putt ME, Ravina B.

Control Clin Trials · 2002-04-01

DOI: 10.1016/s0197-2456(01)00207-0PMID: 11943439

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Animal models of Parkinson's disease.

Betarbet R, Sherer TB, Greenamyre JT.

Bioessays · 2002-04-01

DOI: 10.1002/bies.10067PMID: 11948617

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease.

Restivo DA, Palmeri A, Marchese-Ragona R.

N Engl J Med · 2002-04-01

DOI: 10.1056/nejm200204113461517PMID: 11948283

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Information processing speed and sentence comprehension in Parkinson's disease.

Grossman M, Zurif E, Lee C, Prather P, Kalmanson J, Stern MB, Hurtig HI.

Neuropsychology · 2002-04-01

DOI: 10.1037//0894-4105.16.2.174PMID: 11949709

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Negative priming in patients with Parkinson's disease: evidence for a role of the striatum in inhibitory attentional processes.

Filoteo JV, Rilling LM, Strayer DL.

Neuropsychology · 2002-04-01

DOI: 10.1037//0894-4105.16.2.230PMID: 11949715

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Enhanced negative priming in Parkinson's disease.

Wylie SA, Stout JC.

Neuropsychology · 2002-04-01

DOI: 10.1037/0894-4105.16.2.242PMID: 11949716

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Divergent findings regarding negative priming in Parkinson's disease: A comment on Filoteo et al. (2002) and Wylie and Stout (2002).

Stout JC, Wylie SA, Filoteo JV.

Neuropsychology · 2002-04-01

DOI: 10.1037//0894-4105.16.2.251PMID: 11949717

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Predictors of mortality among nursing home residents with a diagnosis of Parkinson's disease.

Fernandez HH, Lapane KL.

Med Sci Monit · 2002-04-01

PMID: 11951064

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells.

Maruyama W, Takahashi T, Youdim M, Naoi M.

J Neural Transm (Vienna) · 2002-04-01

DOI: 10.1007/s007020200038PMID: 11956966

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Association analysis for genetic variants of the NMDA receptor 2b subunit (GRIN2B) and Parkinson's disease.

Tsai SJ, Liu HC, Liu TY, Cheng CY, Hong CJ.

J Neural Transm (Vienna) · 2002-04-01

DOI: 10.1007/s007020200039PMID: 11956967

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.

Brunt ER, Brooks DJ, Korczyn AD, Montastruc JL, Stocchi F, 043 Study Group.

J Neural Transm (Vienna) · 2002-04-01

DOI: 10.1007/s007020200040PMID: 11956968

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Electrophysiological correlates of visual categorization: evidence for cognitive dysfunctions in early Parkinson's disease.

Antal A, Kéri S, Dibó G, Benedek G, Janka Z, Vécsei L, Bodis-Wollner I.

Brain Res Cogn Brain Res · 2002-04-01

DOI: 10.1016/s0926-6410(01)00090-8PMID: 11958957

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

107.522 articles found

Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in Parkinson's disease.

Animal models of Parkinson's disease.

Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease.

Information processing speed and sentence comprehension in Parkinson's disease.

Negative priming in patients with Parkinson's disease: evidence for a role of the striatum in inhibitory attentional processes.

Enhanced negative priming in Parkinson's disease.

Divergent findings regarding negative priming in Parkinson's disease: A comment on Filoteo et al. (2002) and Wylie and Stout (2002).

Predictors of mortality among nursing home residents with a diagnosis of Parkinson's disease.

The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells.

Association analysis for genetic variants of the NMDA receptor 2b subunit (GRIN2B) and Parkinson's disease.

A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.

Electrophysiological correlates of visual categorization: evidence for cognitive dysfunctions in early Parkinson's disease.

Filters